Biphenyls as potent vitronectin receptor antagonists.: Part 3:: Squaric acid amides

被引:15
|
作者
Urbahns, Klaus
Haerter, Michael
Albers, Markus
Schmidt, Delf
Stelte-Ludwig, Beatrix
Brueggemeier, Ulf
Vaupel, Andrea
Keldenich, Joerg
Lustig, Klemens
Tsujishita, Hideki
Gerdes, Christoph
机构
[1] Bayer Schering Pharma, Bayer Hlthcare AG, Inst Med Chem, D-42096 Wuppertal, Germany
[2] Bayer AG, Combinat Chem Grp, D-51368 Leverkusen, Germany
[3] Bayer Schering Pharma, Bayer Hlthcare AG, Inst Lead Discovery, D-42096 Wuppertal, Germany
[4] Bayer Schering Pharma, Bayer Hlthcare AG, Inst Prot Therapeut, D-42096 Wuppertal, Germany
[5] Bayer Schering Pharma, Bayer Hlthcare AG, Inst Drug Metab & Pharmacol, D-42096 Wuppertal, Germany
[6] Bayer Yakutin Res Ctr, Dept Med Chem, Kyoto, Japan
[7] Bayer Schering Pharma, Bayer Hlthcare AG, Inst Cardiol Hematol, D-42096 Wuppertal, Germany
关键词
vitronectin; urea; arginine; guanidine mimetic; squaric acid amide; alpha nu beta(3); RGD; restenosis; biphenyl; smooth muscle cell;
D O I
10.1016/j.bmcl.2007.09.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Vitronectin receptor (alpha(V)beta 3) antagonists have been implicated as a possible new treatment of restenosis following balloon angioplasty. In this work we investigate a series of novel arginine mimetic scaffolds leading to new insight of the alpha(V)beta 3/ligand interaction. Squaric acid amide 10 is a subnanomolar alpha(V)beta 3 antagonist with improved potency on human smooth muscle cell migration. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6151 / 6154
页数:4
相关论文
共 50 条
  • [1] Biphenyls as potent vitronectin receptor antagonists.: Part 2:: Biphenylalanine ureas
    Urbahns, K
    Härter, M
    Vaupel, A
    Albers, M
    Schmidt, D
    Brüggemeier, U
    Stelte-Ludwig, B
    Gerdes, C
    Tsujishita, F
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1071 - 1074
  • [2] Biphenyls as potent vitronectin receptor antagonists
    Urbahns, K
    Härter, M
    Albers, M
    Schmidt, D
    Stelte-Ludwig, B
    Brüggemeier, U
    Vaupel, A
    Gerdes, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (02) : 205 - 208
  • [3] Synthesis and biological evaluation of potent isonipecotamide-based vitronectin receptor antagonists.
    Ghosh, S
    Andrade-Gordon, P
    Costanzo, M
    De Corte, B
    Hoekstra, WJ
    Kinney, WA
    Luci, DK
    Liu, L
    Maryanoff, BE
    Santulli, R
    Yabut, SC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U22 - U22
  • [4] Orally active, nonpeptide vitronectin receptor (αvβ3) antagonists.
    Miller, WH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
  • [5] Discovery of orally active vitronectin receptor (αvβ3) antagonists.
    Heerding, DA
    Miller, WH
    Willette, R
    Yue, TL
    Lark, M
    Stroup, G
    Badger, A
    Ohlstein, E
    Gowen, M
    Huffman, WF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U567 - U568
  • [6] Dihydropyrimidinone C-5 amides as potent and selective α1A receptor antagonists.
    Rittle, K
    Glass, K
    Barrow, J
    Broten, T
    Chang, R
    Forray, C
    Freidinger, R
    Gluchowski, C
    Lagu, B
    Nagarathnam, D
    Ransom, R
    Selnick, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U18 - U18
  • [7] Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
    Dhanak, D
    Christmann, LT
    Darcy, MG
    Keenan, RM
    Knight, SD
    Lee, J
    Ridgers, LH
    Sarau, HM
    Shah, DH
    White, JR
    Zhang, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1445 - 1450
  • [8] Aryloxadiazolepiperidineamides as potent human H3 receptor antagonists.
    Gfesser, GA
    Zhang, H
    Dinges, J
    Esbenshade, TA
    Yao, BB
    Witte, D
    Miller, TR
    Kang, CH
    Krueger, KM
    Bennani, YL
    Hancock, AA
    Faghih, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U58 - U58
  • [9] Discovery of potent αVβ3 antagonists.
    Jadhav, PK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U568 - U568
  • [10] New highly potent and selective adenosine A3 receptor antagonists.
    Press, NJ
    Fozard, JR
    Beer, D
    Heng, R
    di Padova, F
    Tranter, P
    Trifilieff, A
    Walker, C
    Keller, TH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U79 - U80